Myocardial infarction (MI) remains a leading contributor for morbidity and mortality worldwide [1,2]. While the medical progress regarding diagnostic and therapeutic approaches has improved outcomes significantly in the last decades, disparities still exist in MI care and outcomes based on socioeconomic status and psychosocial factors [2-4]. These social determinants are known to influence cardiovascular health across the disease spectrum [5]. Patients of lower socioeconomic status have higher incidence of MI, worse risk factor control, lower treatment rates, and higher mortality compared to more advantaged groups [6-8].
